Feed BSEM
BS
BioStem Technologies, Inc.
BSEM · OTC
$4.09 +3.98% (+$0.16)
1M +23.31%
Market Cap $67.6M
P/E Ratio -
Div. Yield -
ROE 15.57%
Bulios Fair Price
$5.77
41.0% upside
Current Price
$4.09
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BSEM is currently undervalued relative to its market price. How does it work?
Valuation
97 /100
Cheap P/B 1.73x
P/FCF 10.26x
P/S 1.42x
Growth
100 /100
Growing Rev. growth 90.44%
FCF growth N/A
Book val. growth N/A
Profitability
45 /100
Moderate FCF margin 13.88%
Op. margin 1.45%
Gross margin 93.13%
Quality
12 /100
Poor Asset turnover 0.95x
ROA 13.15%
ROIC 27.41%
Debt
100 /100
Low Current ratio 4.12x
Debt/Equity 0.09x
Net debt/EBITDA N/A
Stability
1 /100
Unstable Profitable years 0
EPS volatility 239.65%
Beta 0.21x
Ask StockBot about BSEM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jason Matuszewski
Employees
0
Headquarters
Fort Lauderdale
Upcoming events
12 AUG
Earnings
Upcoming earnings report